High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
U PopatK van Besien

Abstract

This study was performed to evaluate the outcome of high-dose chemotherapy and autologous transplantation in patients with diffuse B-cell large-cell lymphoma, and, specifically, to evaluate the impact of primary mediastinal localization on the outcome of high-dose chemotherapy. A retrospective review was performed of all patients with diffuse large B-cell lymphoma who underwent autologous marrow or peripheral-blood stem-cell transplantation at our institution between January 1 986 and December 1995. Ninety patients were identified, of whom 31 (34%) had a primary mediastinal B-cell large-cell lymphoma (PML). Cumulative probabilities of disease-free survival, overall survival, and disease progression are 40% (95% confidence interval [CI], 29 to 51), 42% (95% CI, 31 to 53), and 52% (95% CI, 40 to 64), respectively. By univariate analysis, low lactate dehydrogenase (LDH) level and low Ann Arbor stage at transplant were associated with improved survival and disease-free survival. There was a trend for improved disease-free survival and survival for patients with PML. Multivariate stepwise Cox regression analysis showed that LDH level, Ann Arbor stage, and primary mediastinal localization were independent favorable prognostic factors...Continue Reading

Citations

Jun 24, 1999·Annals of Surgical Oncology·S AgrawalD G Coit
Dec 3, 1999·British Journal of Haematology·C R Pinkerton
Jul 9, 2004·International Journal of Hematology·Naohiro SekiguchiKensei Tobinai
May 3, 2008·Leukemia & Lymphoma·José RodríguezMiguel Piris
Jun 11, 2015·Hematological Oncology·Peter W M Johnson
May 2, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K SeidemannUNKNOWN NHL Berlin-Frankfurt-Münster Group
Dec 17, 2008·Hematology·Peter W M Johnson, Andrew J Davies
Jun 19, 2007·Hematological Oncology·E Boleti, P W M Johnson
Apr 19, 2011·Orvosi hetilap·Tamás SchneiderAndrás Rosta
Sep 29, 2011·Current Opinion in Oncology·Koen van Besien
Mar 10, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A A Abou-ElellaJ O Armitage
Apr 1, 2004·Echocardiography·Amgad N MakaryusSmadar Kort
Mar 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K van BesienP Bahaguna
Jun 18, 2018·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Santosha VardhanaCraig H Moskowitz

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
C TondiniG Bonadonna
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
J M VoseJ O Armitage
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Bradford S HoppeJoachim Yahalom
© 2021 Meta ULC. All rights reserved